-
Mashup Score: 12Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries - 2 month(s) ago
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 22
Lung cancer is the leading cause of mortality and person-years of life lost from cancer among US men and women. Early detection has been shown to be associated with reduced lung cancer mortality. Our…
Categories: General Medicine News, Oncologists1Tweet-
#LungCancer is the leading cause of #CancerMortality and person-years-of-life-lost from cancer among US men and women. Find recommendations from on #LungCancerScreening in our latest guideline update. #LungCancerAwarenessMonth https://t.co/zcJSEAUfiV @OncoAlert https://t.co/IRarXbfEhJ
-
-
Mashup Score: 33Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature - 2 month(s) ago
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, an…
Categories: General Medicine News, Onc News and JournalsTweet-
Cancer #PatientNavigation effectively improves participation in screening, access to care, and experience and outcomes. Prior learnings can inform the implementation of future programs worldwide. More economic evaluations are required. 🔗https://t.co/7UbetWGVQ5 https://t.co/GIh73T7lsf
-
-
Mashup Score: 36Testicular cancer in 2023: Current status and recent progress - 2 month(s) ago
Testicular germ cell tumor (GCT) is the most common solid tumor in adolescent and young adult men. Progress in the management of GCT has been made in the last 50 years, with a substantial improvement…
Categories: General Medicine News, Oncologists1Tweet-
This comprehensive #OpenAccess article on testicular cancer reviews contemporary evidence-based treatments for extracranial testicular germ cell tumor, discusses acute and chronic toxic effects, and highlights recent advances and progress in the field. https://t.co/FT4rjkNZ8r https://t.co/9PYYDUN1xO
-
-
Mashup Score: 7Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide - 2 month(s) ago
Advances in biomarker-driven therapies for patients with nonsmall cell lung cancer (NSCLC) both provide opportunities to improve the treatment (and thus outcomes) for patients and pose new challenges…
Categories: General Medicine News, Onc News and JournalsTweet-
The continuing development of new biomarker-driven therapies and evolving indications for their use have intensified the importance of interdisciplinary communication and coordination for patients with or suspected to have #LungCancer. 🔗 https://t.co/i7IeAyTp2s #lcsm https://t.co/0N3Mixv3Tr
-
-
Mashup Score: 34Overlooked barriers to implementation of geriatric assessment - 2 month(s) ago
Click on the article title to read more.
Categories: General Medicine News, Oncologists1Tweet-
To improve #GeriatricAssessment use in oncology, educating oncologists and simplifying the tool isn't enough. @BanuSymington stresses the need to support under-resourced practices, especially in rural areas, to implement GA-based changes. https://t.co/kOzH0d5xID @oncoalert https://t.co/fOKQvOJnGR
-
-
Mashup Score: 23Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey - 2 month(s) ago
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Categories: General Medicine News, Onc News and JournalsTweet-
In this new review, @cslathan et al detail the increasing responsibility of NCI-DCCs to work alongside stakeholders in cancer care and emphasize community outreach and engagement efforts in historically marginalized communities. https://t.co/Exu22Eoh4V @OncoAlert https://t.co/rDO5VKvSqD
-
-
Mashup Score: 24CA: A Cancer Journal for Clinicians Now Accepting Phase III Research - 2 month(s) ago
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.
Categories: General Medicine News, Onc News and JournalsTweet-
CA is now accepting proposals for high-impact Phase 3 trials! Our goal is to democratically disseminate important randomized #ClinicalTrials to the broader #oncology community. Learn more at: https://t.co/HV56RTECKz @arifkamalmd @drdonsdizon @KeithDelman @montypal @OncoAlert https://t.co/YywcDIqhLa
-
-
Mashup Score: 7Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide - 2 month(s) ago
Advances in biomarker-driven therapies for patients with nonsmall cell lung cancer (NSCLC) both provide opportunities to improve the treatment (and thus outcomes) for patients and pose new challenges…
Categories: General Medicine News, Onc News and JournalsTweet-
The continuing development of new biomarker-driven therapies and evolving indications for their use have intensified the importance of interdisciplinary communication and coordination for patients with or suspected to have #LungCancer. 🔗 https://t.co/i7IeAyTp2s #lcsm https://t.co/0N3Mixv3Tr
-
-
Mashup Score: 8Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack‐year history: A systematic review - 2 month(s) ago
Current US lung cancer screening recommendations limit eligibility to adults with a pack-year (PY) history of ≥20 years and the first 15 years since quit (YSQ). The authors conducted a systematic rev…
Categories: General Medicine News, Oncologists1Tweet-
This #LungCancerAwarenessMonth, revisit our 2023 #OpenAccess review article: Quitting smoking lowers risk over time, but people who smoke or used to smoke have higher risk for #lungcancer than those who never smoked. https://t.co/1Zwzx9Q4XQ @KondoKarli @DrMichaelHSR @OncoAlert https://t.co/yOaxi54z2y
-
Keep your eyes out for the @OncoAlert newsletter hitting virtual newsstands today! 📰💻 Today's newsletter highlights the latest global cancer statistics report from @AmericanCancer and @IARCWHO researchers: https://t.co/28O2y5no4G Register for the newsletter below! 👇 https://t.co/aHHxLTdLcQ